Francesco Albano

Improved Outcomes With Retinoic Acid and Arsenic Trioxide Compared With Retinoic Acid and Chemotherapy in Non–High-Risk Acute Promyelocytic Leukemia: Final Results of the Randomized Italian-German APL0406 Trial

Uwe Platzbecker, Giuseppe Avvisati, Laura Cicconi et al. · Journal of Clinical Oncology · 2016 · 375 citations · Full text

A clinical-molecular prognostic model to predict survival in patients with post polycythemia vera and post essential thrombocythemia myelofibrosis

Francesco Passamonti, Toni Giorgino, Barbara Mora et al. · Leukemia · 2017 · 323 citations · Full text

Hematological Malignancy, Thrombosis, Translational Medicine +9

GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemia

Adriano Venditti, Alfonso Piciocchi, Anna Candoni et al. · Blood · 2019 · 208 citations · Full text

Extramedullary Involvement at Relapse in Acute Promyelocytic Leukemia Patients Treated or Not With All-<i>Trans</i> Retinoic Acid: A Report by the Gruppo Italiano Malattie Ematologiche dell’Adulto

Giorgina Specchia, Francesco Lo‐Coco, Marco Vignetti et al. · Journal of Clinical Oncology · 2001 · 134 citations

Differences among young adults, adults and elderly chronic myeloid leukemia patients

Fabio Castagnetti, Gabriele Gugliotta, Michele Baccarani et al. · Annals of Oncology · 2014 · 97 citations · Full text

Hematological Malignancy, Family Medicine, Young Adults +8